RedHill Biopharma Statistics
Total Valuation
RDHL has a market cap or net worth of $3.96 million. The enterprise value is -$336,504.
Important Dates
The last earnings date was Thursday, April 10, 2025, before market open.
| Earnings Date | Apr 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RDHL has 1.75 million shares outstanding. The number of shares has increased by 375.56% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.75M |
| Shares Change (YoY) | +375.56% |
| Shares Change (QoQ) | +9.56% |
| Owned by Insiders (%) | 1.13% |
| Owned by Institutions (%) | 6.20% |
| Float | 1.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.34 |
| Forward PS | n/a |
| PB Ratio | -0.84 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.54
| Current Ratio | 0.54 |
| Quick Ratio | 0.34 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -222.80 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -37.28% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 293.16% |
| Revenue Per Employee | $229,800 |
| Profits Per Employee | -$236,229 |
| Employee Count | 35 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 0.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.75% in the last 52 weeks. The beta is 4.43, so RDHL's price volatility has been higher than the market average.
| Beta (5Y) | 4.43 |
| 52-Week Price Change | -79.75% |
| 50-Day Moving Average | 3.19 |
| 200-Day Moving Average | 7.00 |
| Relative Strength Index (RSI) | 40.62 |
| Average Volume (20 Days) | 432,650 |
Short Selling Information
| Short Interest | 29,973 |
| Short Previous Month | 46,646 |
| Short % of Shares Out | 4.11% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, RDHL had revenue of $8.04 million and -$8.27 million in losses. Loss per share was -$6.71.
| Revenue | 8.04M |
| Gross Profit | 4.85M |
| Operating Income | -12.25M |
| Pretax Income | 23.92M |
| Net Income | -8.27M |
| EBITDA | -12.16M |
| EBIT | -12.25M |
| Loss Per Share | -$6.71 |
Full Income StatementBalance Sheet
The company has $4.62 million in cash and $356,000 in debt, giving a net cash position of $4.26 million or $2.43 per share.
| Cash & Cash Equivalents | 4.62M |
| Total Debt | 356,000 |
| Net Cash | 4.26M |
| Net Cash Per Share | $2.43 |
| Equity (Book Value) | -4.68M |
| Book Value Per Share | -3.63 |
| Working Capital | -10.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.37 million and capital expenditures -$9,000, giving a free cash flow of -$9.38 million.
| Operating Cash Flow | -9.37M |
| Capital Expenditures | -9,000 |
| Free Cash Flow | -9.38M |
| FCF Per Share | -$5.35 |
Full Cash Flow StatementMargins
Gross margin is 60.31%, with operating and profit margins of -152.36% and -102.80%.
| Gross Margin | 60.31% |
| Operating Margin | -152.36% |
| Pretax Margin | -102.80% |
| Profit Margin | -102.80% |
| EBITDA Margin | -151.14% |
| EBIT Margin | -152.36% |
| FCF Margin | n/a |